Publicaciones en colaboración con investigadores/as de Imperial College Healthcare NHS Trust (10)

2024

  1. Early inflammation as a footprint of increased mortality risk in infants living with HIV from three African countries

    Scientific Reports, Vol. 14, Núm. 1

2021

  1. Early ART initiation during infancy preserves natural killer cells in young European adolescents living with HIV (CARMA cohort)

    Journal of the International AIDS Society, Vol. 24, Núm. 7

  2. Faster Initial Viral Decay in Female Children Living with HIV

    Journal of the Pediatric Infectious Diseases Society, Vol. 10, Núm. 5, pp. 674-676

  3. Malignancies among children and young people with HIV in Western and Eastern Europe and Thailand the European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) study group

    AIDS, Vol. 35, Núm. 12, pp. 1973-1985

  4. Size of HIV-1 reservoir is associated with telomere shortening and immunosenescence in early-treated European children with perinatally acquired HIV-1

    Journal of the International AIDS Society, Vol. 24, Núm. 11

  5. T cell immune discriminants of HIV reservoir size in a pediatric cohort of perinatally infected individuals

    PLoS Pathogens, Vol. 17, Núm. 4

  6. The CARMA Study: Early Infant Antiretroviral Therapy - Timing Impacts on Total HIV-1 DNA Quantitation 12 Years Later

    Journal of the Pediatric Infectious Diseases Society, Vol. 10, Núm. 3, pp. 295-301

2019

  1. Reduced Time to Suppression among Neonates with HIV Initiating Antiretroviral Therapy Within 7 Days after Birth

    Journal of Acquired Immune Deficiency Syndromes, Vol. 82, Núm. 5, pp. 483-490

2018

  1. Early and highly suppressive antiretroviral therapy are main factors associated with low viral reservoir in European perinatally HIV-infected children

    Journal of Acquired Immune Deficiency Syndromes

2011

  1. First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: An open-label, randomised phase 2/3 trial

    The Lancet Infectious Diseases, Vol. 11, Núm. 4, pp. 273-283